14592

    532843

    FORTIS

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    FORTIS HEALTHCARE LTD Share Price Today

    FORTIS HEALTHCARE LTD is currently trading at ₹940, down by ₹5.0 from the previous close. The stock touched an intraday high of ₹979.60 and a low of ₹938.00 during the latest trading session. Over the past one year, FORTIS HEALTHCARE LTD has delivered a return of 10.21%, while the stock has declined 1.24% in the last one month.

    FORTIS HEALTHCARE LTD performance

    Today’s low Today’s high
    ₹ 938.00 ₹ 979.60
    ₹ 940.00
    52 week low 52 week high
    ₹ 766.80 ₹ 1104.30
    ₹ 940.00
    Open Price ₹ 953.80
    Prev. Close ₹ 945.00
    Volume (Shares) 2160190.00
    Total traded value ₹ 20305.78
    Upper Circuit ₹ 1039.50
    Lower Circuit ₹ 850.50
    info

    Investment Returns

    Over 1 Month -1.24% Over 3 Months 2.38% Over 6 Months 13.47% Over 1 Year 10.21%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    FORTIS HEALTHCARE LTD fundamentals


    • Market cap (Cr) 70,966.10
    • P/E Ratio (TTM) 309.77
    • Beta 0.84
    • Book Value / share 122.24
    • Return on equity 2.13%
    • EPS (TTM) 2.58
    • Dividend yield 0.11%
    • Net profit/quarter (Cr) 24.98
    info icon alternate text
    • Market cap (Cr) 71,245.40
    • P/E Ratio (TTM) 309.77
    • Beta 0.72
    • Book Value / share 122.24
    • Return on equity 2.13%
    • EPS (TTM) 2.58
    • Dividend yield 0.11%
    • Net profit/quarter (Cr) 24.98
    info icon alternate text

    FORTIS HEALTHCARE LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 460.73
    Operating Expense 427.82
    Net Profit 24.98
    Net Profit Margin (%) 5.42
    Earnings Per Share (EPS) 0.33
    EBITDA 114.77
    Effective Tax Rate (%) 33.15
    Particulars DEC 2025 (Values in Cr)
    Revenue 442.93
    Operating Expense 429.45
    Net Profit 28.40
    Net Profit Margin (%) 6.41
    Earnings Per Share (EPS) 0.38
    EBITDA 119.46
    Effective Tax Rate (%) 16.91
    Particulars SEP 2025 (Values in Cr)
    Revenue 455.81
    Operating Expense 435.08
    Net Profit 125.09
    Net Profit Margin (%) 27.44
    Earnings Per Share (EPS) 1.65
    EBITDA 214.12
    Effective Tax Rate (%) 7.32
    Particulars JUN 2025 (Values in Cr)
    Revenue 433.03
    Operating Expense 426.95
    Net Profit 51.88
    Net Profit Margin (%) 11.98
    Earnings Per Share (EPS) 0.69
    EBITDA 145.00
    Effective Tax Rate (%) 17.61
    Particulars MAR 2025 (Values in Cr)
    Revenue 388.47
    Operating Expense 399.93
    Net Profit -42.23
    Net Profit Margin (%) -10.87
    Earnings Per Share (EPS) -0.56
    EBITDA 43.53
    Effective Tax Rate (%) -8.56
    Particulars MAR 2026 (Values in Cr)
    Revenue 1792.50
    Operating Expense 1719.32
    Net Profit 230.34
    Net Profit Margin (%) 12.85
    Earnings Per Share (EPS) 3.05
    EBITDA 593.35
    Effective Tax Rate (%) 14.52
    Particulars MAR 2025 (Values in Cr)
    Revenue 1445.89
    Operating Expense 1414.87
    Net Profit 63.79
    Net Profit Margin (%) 4.41
    Earnings Per Share (EPS) 0.84
    EBITDA 338.92
    Effective Tax Rate (%) 44.24
    Particulars MAR 2024 (Values in Cr)
    Revenue 1181.42
    Operating Expense 1171.51
    Net Profit 199.45
    Net Profit Margin (%) 16.88
    Earnings Per Share (EPS) 2.64
    EBITDA 429.46
    Effective Tax Rate (%) 19.10
    Particulars MAR 2023 (Values in Cr)
    Revenue 1052.93
    Operating Expense 1141.91
    Net Profit 96.24
    Net Profit Margin (%) 9.14
    Earnings Per Share (EPS) 1.27
    EBITDA 331.00
    Effective Tax Rate (%) 11.60
    Particulars MAR 2022 (Values in Cr)
    Revenue 862.61
    Operating Expense 989.42
    Net Profit -13.25
    Net Profit Margin (%) -1.53
    Earnings Per Share (EPS) -0.18
    EBITDA 233.22
    Effective Tax Rate (%) -47.38
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 131.07
    ROE % 11.31
    ROCE % 13.36
    Total Debt to Total Equity 0.32
    EBITDA Margin 22.41
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 118.11
    ROE % 9.42
    ROCE % 11.28
    Total Debt to Total Equity 0.22
    EBITDA Margin 19.44
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 101.50
    ROE % 7.81
    ROCE % 9.65
    Total Debt to Total Equity 0.14
    EBITDA Margin 18.55
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 95.93
    ROE % 6.79
    ROCE % 7.51
    Total Debt to Total Equity 0.16
    EBITDA Margin 17.82
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 81.84
    ROE % 7.45
    ROCE % 7.75
    Total Debt to Total Equity 0.23
    EBITDA Margin 18.83
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 122.24
    ROE % 2.13
    ROCE % 3.95
    Total Debt to Total Equity 0.22
    EBITDA Margin 29.99
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 120.19
    ROE % 1.41
    ROCE % 3.26
    Total Debt to Total Equity 0.15
    EBITDA Margin 30.13
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 120.37
    ROE % 1.37
    ROCE % 2.41
    Total Debt to Total Equity 0.08
    EBITDA Margin 27.42
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 118.73
    ROE % 0.61
    ROCE % 1.69
    Total Debt to Total Equity 0.11
    EBITDA Margin 25.99
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 117.47
    ROE % 0.08
    ROCE % 1.35
    Total Debt to Total Equity 0.14
    EBITDA Margin 27.88
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 543.71
    Total Assets 15966.22
    Total Liabilities 15966.22
    Total Equity 10168.50
    Share Outstanding 75
    Price to Book Ratio 6.50
    Return on Assets (%) 6.52
    Return on Capital (%) 7.99
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 507.99
    Total Assets 13691.52
    Total Liabilities 13691.52
    Total Equity 9169.39
    Share Outstanding 75
    Price to Book Ratio 5.81
    Return on Assets (%) 5.65
    Return on Capital (%) 6.81
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 598.39
    Total Assets 13288.78
    Total Liabilities 13288.78
    Total Equity 8556.13
    Share Outstanding 75
    Price to Book Ratio 3.49
    Return on Assets (%) 4.50
    Return on Capital (%) 6.36
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 362.72
    Total Assets 12433.60
    Total Liabilities 12433.60
    Total Equity 8100.38
    Share Outstanding 75
    Price to Book Ratio 2.19
    Return on Assets (%) 4.73
    Return on Capital (%) 6.69
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 412.69
    Total Assets 11884.74
    Total Liabilities 11884.74
    Total Equity 7008.25
    Share Outstanding 75
    Price to Book Ratio 2.47
    Return on Assets (%) 4.67
    Return on Capital (%) 6.96
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 4.43
    Total Assets 11994.17
    Total Liabilities 11994.17
    Total Equity 9228.74
    Share Outstanding 75
    Price to Book Ratio 6.50
    Return on Assets (%) 1.92
    Return on Capital (%) 2.06
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 49.45
    Total Assets 11999.06
    Total Liabilities 11999.06
    Total Equity 9074.00
    Share Outstanding 75
    Price to Book Ratio 5.81
    Return on Assets (%) 0.53
    Return on Capital (%) 0.59
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 119.94
    Total Assets 10386.91
    Total Liabilities 10386.91
    Total Equity 9087.16
    Share Outstanding 75
    Price to Book Ratio 3.49
    Return on Assets (%) 1.92
    Return on Capital (%) 2.12
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 1.03
    Total Assets 10368.67
    Total Liabilities 10368.67
    Total Equity 8963.53
    Share Outstanding 75
    Price to Book Ratio 2.19
    Return on Assets (%) 0.92
    Return on Capital (%) 1.03
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.07
    Total Assets 10426.20
    Total Liabilities 10426.20
    Total Equity 8868.56
    Share Outstanding 75
    Price to Book Ratio 2.47
    Return on Assets (%) -0.12
    Return on Capital (%) -0.14
    Particulars MAR 2026 (Values in Cr)
    Net Income 1365.84
    Cash from Operations 1871.38
    Cash from Investing -1538.40
    Cash from Financing 163.76
    Net change in Cash 228.06
    Free Cash Flow 2816.82
    Particulars MAR 2025 (Values in Cr)
    Net Income 1007.04
    Cash from Operations 1533.59
    Cash from Investing -779.37
    Cash from Financing -713.85
    Net change in Cash -69.75
    Free Cash Flow 2380.52
    Particulars MAR 2024 (Values in Cr)
    Net Income 857.96
    Cash from Operations 1321.90
    Cash from Investing -886.36
    Cash from Financing -86.45
    Net change in Cash 124.51
    Free Cash Flow 2264.37
    Particulars MAR 2023 (Values in Cr)
    Net Income 813.67
    Cash from Operations 1096.47
    Cash from Investing -373.69
    Cash from Financing -471.22
    Net change in Cash -21.43
    Free Cash Flow 1557.60
    Particulars MAR 2022 (Values in Cr)
    Net Income 987.78
    Cash from Operations 1076.76
    Cash from Investing -514.37
    Cash from Financing -517.31
    Net change in Cash -166.23
    Free Cash Flow 1292.25
    Particulars MAR 2026 (Values in Cr)
    Net Income 269.49
    Cash from Operations 220.58
    Cash from Investing 11.31
    Cash from Financing -176.29
    Net change in Cash -48.86
    Free Cash Flow 527.84
    Particulars MAR 2025 (Values in Cr)
    Net Income 114.41
    Cash from Operations 331.99
    Cash from Investing -1572.20
    Cash from Financing 1275.90
    Net change in Cash 37.71
    Free Cash Flow 697.19
    Particulars MAR 2024 (Values in Cr)
    Net Income 246.56
    Cash from Operations 241.50
    Cash from Investing 44.45
    Cash from Financing -245.34
    Net change in Cash 17.55
    Free Cash Flow 566.13
    Particulars MAR 2023 (Values in Cr)
    Net Income 108.88
    Cash from Operations 232.01
    Cash from Investing 204.64
    Cash from Financing -395.43
    Net change in Cash 7.59
    Free Cash Flow 285.66
    Particulars MAR 2022 (Values in Cr)
    Net Income -8.98
    Cash from Operations 125.28
    Cash from Investing 237.73
    Cash from Financing -319.82
    Net change in Cash -5.59
    Free Cash Flow 152.10
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8955.00 65.82 13.59 128759.16 6680.00 9099.95
    FORTIS MALAR HOSPITALS LIMITED 50.61 22.90 2.76 94.85 40.75 76.00
    SHREE PACETRONIX LTD. 137.05 16.35 2.88 51.39 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.01 0.00 2.72 22.81 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8955.00 85.77 12.92 128759.16 6680.00 9099.95
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 36.05 0.00 -8.77 26.93 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5916.50 26.30 4.90 6472.65 5010.00 6725.00

    FORTIS HEALTHCARE LTD shareholding pattern

    Holding
    11.4%
    31.16%
    25.19%
    32.23%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    FORTIS HEALTHCARE LTD Technicals Summary

    940.00 -0.52 redarrow
    red-green-graph indicator
    12 Bearish
    4 Bullish
    • 5 Days 947.70
    • 26 Days 955.40
    • 10 Days 950.20
    • 50 Days 952.60
    • 12 Days 951.20
    • 100 Days 938.50
    • 20 Days 954.30
    • 200 Days 911.40
    946.43 PIVOT
    First Support 939.27 First Resistance 952.17 Second Support 933.53 Second Resistance 959.33 Third Support 926.37 Third Resistance 965.07
    RSI 45.11 ADX 16.35 MACD -4.20 Williams % R -71.43 Commodity Channel Index (CCI) -75.80
    Date 2026-07-31 Week 461683.00 Same Day 401749.00 Month 648161.00
    1 Year 0.84 3 Year 0.66
    Over 1 Month
    -1.24% down
    Over 1 Year
    10.21% down
    Over 3 Months
    2.38% down
    Over 3 Years
    39.80% down
    Over 6 Months
    13.47% down
    Over 5 Years
    30.32% down

    FORTIS HEALTHCARE LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Jul 2026 1.0 Final 24 Jul 2026 Equity shares
    25 Jul 2025 1.0 Final 25 Jul 2025 Equity shares
    24 Jul 2024 1.0 Final 24 Jul 2024 Equity shares
    20 Jul 2023 1.0 Final 20 Jul 2023 Equity shares
    Dividend date Dividend amount Dividend type Record date Instrument type
    24 Jul 2026 1.0 Final 24 Jul 2026 Equity shares
    25 Jul 2025 1.0 Final 25 Jul 2025 Equity shares
    24 Jul 2024 1.0 Final 24 Jul 2024 Equity shares
    20 Jul 2023 1.0 Final 20 Jul 2023 Equity shares

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Fortis Healthcare Ltd?

    Answer Field

    Fortis Healthcare Ltd share price is for NSE ₹ 940.00 & for BSE ₹ 943.70 as on Aug 03 2026 03:30 PM.

    What is the Market Cap of Fortis Healthcare Ltd Share?

    Answer Field

    The market cap of Fortis Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 03 2026 03:30 PM.

    What is the 52 Week High and Low of Fortis Healthcare Ltd?

    Answer Field

    The 52 Week High and Low of Fortis Healthcare Ltd for NSE is ₹ 1,104.30 and ₹ 766.80 and for BSE is ₹ 1,105.00 and ₹ 767.30.

    What is 1 year return for Fortis Healthcare Ltd?

    Answer Field

    The 1 year returns on the stock has been 10.21%.

    What is the P/E Ratio of Fortis Healthcare Ltd Share?

    Answer Field

    As on Aug 03 2026 03:30 PM the price-to-earnings (PE) ratio for Fortis Healthcare Ltd share is 309.77.

    What is the PB ratio of Fortis Healthcare Ltd Share?

    Answer Field

    As on Aug 03 2026 03:30 PM, the price-to-book (PB) ratio for Fortis Healthcare Ltd share is 122.24.

    How to Buy Fortis Healthcare Ltd Share?

    Answer Field

    You can trade in Fortis Healthcare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Fortis Healthcare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Fortis Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Fortis Healthcare Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |